LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 231 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $379,755 | +12.4% | 5,195 | +9.8% | 0.00% | +33.3% |
| Q4 2023 | $337,888 | +16.5% | 4,731 | -2.3% | 0.00% | 0.0% |
| Q3 2023 | $290,073 | -28.2% | 4,841 | -13.6% | 0.00% | -25.0% |
| Q2 2023 | $403,904 | -16.2% | 5,602 | -14.5% | 0.00% | -20.0% |
| Q1 2023 | $481,892 | – | 6,551 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,199,766 | $130,078,630,000 | 35.65% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 852,053 | $92,380,000 | 5.34% |
| OBERWEIS ASSET MANAGEMENT INC/ | 101,127 | $10,964,000 | 3.08% |
| Timpani Capital Management LLC | 68,160 | $7,390,000 | 3.00% |
| ASHFORD CAPITAL MANAGEMENT INC | 103,420 | $11,213,000 | 2.64% |
| First Light Asset Management, LLC | 56,818 | $6,160,000 | 2.58% |
| Conestoga Capital Advisors, LLC | 286,162 | $31,026,000 | 2.51% |
| OAK RIDGE INVESTMENTS LLC | 955,599 | $103,606,000 | 2.48% |
| RK Capital | 127,983 | $13,876,000 | 2.42% |
| Nichols Asset Management LLC | 93,170 | $10,101,000 | 2.20% |